Bharat Biotech, Aurobindo and Hetero sign multi crore investment deals in Telangana

Written By :  Ruchika Sharma
Published On 2025-12-10 10:55 GMT   |   Update On 2025-12-10 10:56 GMT
Advertisement

Hyderabad: Telangana's investment momentum surged on tuesday as the state government announced over Rs 1 lakh crore investment agreements with industry heavyweights, including Aurobindo Pharma, Hetero, Bharat Biotech, and Reliance Consumer Products Limited on the final day of the ‘Telangana Rising Global Summit 2025’.

This comes on the heels of an impressive Rs 2.43 lakh crore worth of investment MOUs signed on Monday, underscoring the state’s rising appeal as a global business and life sciences hub.

Advertisement

As per PTI, Reliance Consumer Products Limited (RCPL) proposes to set up a multi-product FMCG manufacturing facility for beverages, snacks, confectionery and other consumer products on 100 acres in Telangana with an investment of Rs 1,500 crore. The project is expected to create 1,000 direct jobs.

Vintage Coffee and Beverages Ltd signed an MoU to expand its Telangana operations by establishing an export-oriented premium freeze-dried coffee (FDC) plant with an investment of Rs 1,100 crore.
JCK Infra Projects Limited will set up data centre facilities and ancillary infrastructure services with an investment of Rs 9,000 crore, generating over 2,000 jobs.
RCT Energy India Pvt Ltd proposes to invest Rs 2,500 crore in the state in three phases, creating more than 1,600 jobs.
Hetero Group plans to establish large-scale pharmaceutical formulation facilities in Telangana, enhancing the state’s manufacturing capabilities for domestic and global markets.
The proposed investment of Rs 1,800 crore is expected to generate more than 9,000 direct and indirect jobs over the next two years.
Bharat Biotech plans to set up a state-of-the-art contract research, development and manufacturing organisation (CRDMO) facility in Telangana with an investment of Rs 1,000 crore.
Aurobindo Pharma signed an MoU with the state to expand and develop its capabilities in complex generics, injectables, oral solid formulations, biosimilars and biologics.
The proposed investment of Rs 2,000 crore is expected to create more than 3,000 direct and indirect jobs over the next two to three years.
Investments finalised on the second day stood at Rs 1,04,350 crore, the release added.

Read also: Big investment push: Sun Pharma Labs to set up Rs 3000 crore facility in MP

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News